Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 18,178 shares, a decrease of 87.0% from the June 15th total of 139,841 shares. Based on an average trading volume of 44,335 shares, the days-to-cover ratio is currently 0.4 days. Approximately 4.2% of the company’s stock are sold short.
Wall Street Analyst Weigh In
AKAN has been the topic of a number of recent research reports. Weiss Ratings downgraded Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. Wall Street Zen raised Akanda to a “sell” rating in a research report on Saturday, May 30th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Akanda presently has an average rating of “Sell”.
Check Out Our Latest Analysis on AKAN
Akanda Price Performance
Akanda (NASDAQ:AKAN – Get Free Report) last posted its earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.
Akanda Company Profile
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
See Also
- Five stocks we like better than Akanda
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
